bw a1433u has been researched along with atropine in 1 studies
Studies (bw a1433u) | Trials (bw a1433u) | Recent Studies (post-2010) (bw a1433u) | Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) |
---|---|---|---|---|---|
26 | 0 | 0 | 26,711 | 1,259 | 1,697 |
Protein | Taxonomy | bw a1433u (IC50) | atropine (IC50) |
---|---|---|---|
cystic fibrosis transmembrane conductance regulator | Homo sapiens (human) | 21.41 | |
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 1.012 | |
Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.0067 | |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.0007 | |
Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.001 | |
Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.001 | |
Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.001 | |
Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.001 | |
Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.0009 | |
Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.001 | |
Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0015 | |
Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.0021 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.354 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 1.012 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ferrara, JJ; Flint, LM; Force, SD; Franklin, EW; Hyman, AL; Lippton, HL; Taheri, PA | 1 |
1 other study(ies) available for bw a1433u and atropine
Article | Year |
---|---|
Analysis of regional hemodynamic regulation in response to scald injury.
Topics: Adamantane; Animals; Arginine; Atropine; Blood Pressure; Burns; Diphenhydramine; Dogs; Femoral Artery; Hemodynamics; Hindlimb; Histamine; Isoproterenol; Meclofenamic Acid; Methoxamine; Methysergide; Morpholines; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitroglycerin; Pulmonary Circulation; Ranitidine; Regional Blood Flow; Ritanserin; Serotonin; Serotonin Receptor Agonists; Time Factors; Triazines; Ultrasonography; Vascular Resistance; Vasodilation; Verapamil; Xanthines | 1994 |